ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health Care • South Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
•05 Nov 2023 12:49

Korea Short Sell Ban: Background, Manipulation, Holdings, Flows, Short Interest, Implications

Media reports indicate that there could be a temporary short sell ban in Korea. This could lead to futures backwardation, market manipulation and a...

Logo
1.4k Views
Share
•17 Jan 2022 03:13

Long-Short Trade of KOSPI200 & KOSDAQ150 Amid Osstem Implant Employee Embezzlement Disaster

There is a long-short trade that is setting up nicely amidst the Osstem Implant employee embezzlement disaster. Osstem Implant is involved in an...

Logo
612 Views
Share
•30 Aug 2021 11:19

Critical Supports Holding in the US, Europe, & Japan; Buying Health Care, Utilities, Materials, Tech

Various indicators are making a turn for the better, including early signs of interest rates bottoming in the US and Germany, a false breakdown in...

Logo
332 Views
Share
•30 Sep 2020 08:23

Korea Stock Market Monthly Recap #52 (September 2020)

Review of Top 10 Issues Related to Korean Stock Market, Economy, Politics in September 2020

Logo
413 Views
Share
•24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
493 Views
Share
x